New advances in treating inherited retinal diseases highlighted in Human Gene Therapy

May 8, 2012, Mary Ann Liebert, Inc.

Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive results in animal models of human retinal disease continue to emerge, as reported in several articles published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The articles are available free on the Human Gene Therapy website at http://www.liebertpub.com/hum.

After 20 years of promising research, testing in animal models, and initial clinical trial results of to treat retinal dystrophies, Robin Ali, University College London Institute of Ophthalmology (UK) is "optimistic about the future prospects for retinal gene therapy" mainly because the retina has proven to be a good and accessible target for gene delivery, and scientists have developed efficient and safe viral delivery systems that can successfully introduce therapeutic genes into in the retina. The main challenge now is to increase the number of gene therapies in clinical trials and to optimize these treatments for patients, says Dr. Ali in the Commentary "Gene Therapy for Retinal Dystrophies: Twenty Years in the Making."

Retinitis pigmentosa (RP) is one group of inherited disorders that causes degeneration of the retina due to various gene mutations. Astra Dinculescu, University of Florida, Gainesville, and colleagues from University of Pennsylvania (Philadelphia), National Autonomous University of Mexico, and Glasgow Caledonian University (Scotland) provide that gene-based therapy may be able to replace the in one type of RP in humans. They demonstrate that replacement of the mutant gene in a mouse model of RP prevented subsequent degeneration of the retina in the article "Gene Therapy for Retinitis Pigmentosa Caused by MRFP Mutations: Human Phenotype and Preliminary Proof of Concept."

Haoyu Mao and coauthors from University of Florida, Gainesville, and University of North Texas Health Science Center (Fort Worth) showed long-term success in maintaining normal retinal structure and function following delivery of a human rhodopsin gene to a mouse model of RP. Their findings are reported in the article "Long-Term Rescue of Retinal Structure and Function by Rhodopsin RNA Replacement with a Single Adeno-Associated Viral Vector in P23H RHO Transgenic Mice."

"Inherited diseases affecting retinal function are likely to be in the first wave of commercial successes," says James M. Wilson, MD, PhD, Editor-in-Chief of , and Director of the Gene Therapy Program, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Explore further: Latest advances in gene therapy for ocular disease are highlighted in Human Gene Therapy

Related Stories

Latest advances in gene therapy for ocular disease are highlighted in Human Gene Therapy

May 9, 2011
Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body. A series of articles available online ...

Study demonstrates potential of new gene vector to broaden treatment of eye diseases

June 22, 2011
Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other ...

Recommended for you

Two new breast cancer genes emerge from Lynch syndrome gene study

January 18, 2018
Researchers at Columbia University Irving Medical Center and NewYork-Presbyterian have identified two new breast cancer genes. Having one of the genes—MSH6 and PMS2—approximately doubles a woman's risk of developing breast ...

Can mice really mirror humans when it comes to cancer?

January 18, 2018
A new Michigan State University study is helping to answer a pressing question among scientists of just how close mice are to people when it comes to researching cancer.

A centuries-old math equation used to solve a modern-day genetics challenge

January 18, 2018
Researchers developed a new mathematical tool to validate and improve methods used by medical professionals to interpret results from clinical genetic tests. The work was published this month in Genetics in Medicine.

Peers' genes may help friends stay in school, new study finds

January 18, 2018
While there's scientific evidence to suggest that your genes have something to do with how far you'll go in school, new research by a team from Stanford and elsewhere says the DNA of your classmates also plays a role.

Epigenetics study helps focus search for autism risk factors

January 16, 2018
Scientists have long tried to pin down the causes of autism spectrum disorder. Recent studies have expanded the search for genetic links from identifying genes toward epigenetics, the study of factors that control gene expression ...

Group recreates DNA of man who died in 1827 despite having no body to work with

January 16, 2018
An international team of researchers led by a group with deCODE Genetics, a biopharmaceutical company in Iceland, has partly recreated the DNA of a man who died in 1827, despite having no body to take tissue samples from. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.